CTSB and cancer: Concerning the utilization of amide bond in the linker as the unit tethering the drug and the peptide, it can be tailored to be cleaved based on the targeted tissue and/or type of cancer where a specific protease is statistically upregulated (i.e., cathepsin B upregulated in various malignancies including lung, brain, prostate and breast [102]).